Blood B Cell Depletion Reflects Immunosuppression Induced by Live-Attenuated Infectious Bursal Disease Vaccines
An Erratum on
Blood B cell depletion reflects immunosuppression induced by live-attenuated infectious bursal disease vaccines
by Courtillon, C., Allée, C., Amelot, M., Keita, A., Bougeard, S., Härtle, S., Rouby, J.-C., Eterradossi, N., and Soubies, S. M. (2022). Front. Vet. Sci. 9:871549. doi: 10.3389/fvets.2022.871549
Due to a production error, there was a mistake in Figure 3 as published. The text in Figures 3A, B was not displaying correctly. The corrected Figure 3 appears below.
Figure 3. Implementation of a modified European Pharmacopoeia-derived protocol for IBDV immunosuppression testing. (A) Layout of animal experiment 3. Extra analyses compared to animal experiments 1 and 2 appear in red text. (B) Percentage of clinically protected chicks observed after velogenic Newcastle Disease Virus challenge. Different letters indicate statistically significant differences (p < 0.05) between groups using Fisher's exact test with FDR adjustment method for multiple pairwise comparisons. (C) Serological response to NDV vaccination during experiment 3. Horizontal bars indicate the median of each group. Different letters indicate statistically significant differences (p < 0.05) between groups using Kruskal-Wallis test. (D) Blood B cell concentrations prior to NDV vaccination (“15 days,” left panel), and prior to NDV challenge (“29 days,” right panel). Different letters indicate statistically significant differences (p < 0.05) between groups using Kruskal-Wallis test.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: IBDV, live-attenuated vaccine, vaccine safety, immunosuppression, B cells, replication
Citation: Frontiers Production Office (2023) Erratum: Blood B cell depletion reflects immunosuppression induced by live-attenuated infectious bursal disease vaccines. Front. Vet. Sci. 10:1236998. doi: 10.3389/fvets.2023.1236998
Received: 08 June 2023; Accepted: 08 June 2023;
Published: 27 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org